🇺🇸 FDA
Patent

US 10232035

Conditionally replication deficient herpes virus and use thereof in vaccines

granted A61KA61K2039/5254A61K2039/544

Quick answer

US patent 10232035 (Conditionally replication deficient herpes virus and use thereof in vaccines) held by The Regents of the University of Colorado, a Body Corporate expires Mon Mar 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado, a Body Corporate
Grant date
Tue Mar 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K2039/5254, A61K2039/544, A61K2039/70, A61K39/12